4//SEC Filing
Tassey Kenneth A. Jr 4
Accession 0001102624-12-000239
CIK 0001473579other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 9:38 PM ET
Size
4.5 KB
Accession
0001102624-12-000239
Insider Transaction Report
Form 4
Tassey Kenneth A. Jr
DirectorPresident, COO10% Owner
Transactions
- Sale
Common Stock
2012-03-23$0.25/sh−160,000$40,000→ 3,040,000 total
Documents
Issuer
Boston Therapeutics, Inc.
CIK 0001473579
Entity typeother
Related Parties
1- filerCIK 0001540212
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 9:38 PM ET
- Size
- 4.5 KB